17 related articles for article (PubMed ID: 37017673)
1. Cocktail of lipophilic and hydrophilic chemotherapeutics in high-load core@shell nanocarriers to treat pancreatic tumours.
Rudolph D; Ischyropoulou M; Pfeifer J; Napp J; Schepers U; Alves F; Feldmann C
Nanoscale Adv; 2024 Jan; 6(3):973-984. PubMed ID: 38298597
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent Sulfonate-Based Inorganic-Organic Hybrid Nanoparticles for Staining and Imaging.
Poß M; Zittel E; Meschkov A; Schepers U; Feldmann C
Bioconjug Chem; 2018 Aug; 29(8):2818-2828. PubMed ID: 30004681
[TBL] [Abstract][Full Text] [Related]
3. Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids.
Kaiser TK; Khorenko M; Moussavi A; Engelke M; Boretius S; Feldmann C; Reichardt HM
J Control Release; 2020 Mar; 319():360-370. PubMed ID: 31923534
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Fluorescent Hybrid Nanoparticles for Traceable Delivery of Glucocorticoids to Inflammatory Sites.
Napp J; Markus MA; Heck JG; Dullin C; Möbius W; Gorpas D; Feldmann C; Alves F
Theranostics; 2018; 8(22):6367-6383. PubMed ID: 30613305
[TBL] [Abstract][Full Text] [Related]
5. Saline hybrid nanoparticles with phthalocyanine and tetraphenylporphine anions showing efficient singlet-oxygen production and photocatalysis.
Poß M; Gröger H; Feldmann C
Chem Commun (Camb); 2018 Jan; 54(10):1245-1248. PubMed ID: 29340360
[TBL] [Abstract][Full Text] [Related]
6. Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy.
Khorenko M; Rand U; Cicin-Sain L; Feldmann C
ACS Biomater Sci Eng; 2022 Apr; 8(4):1596-1603. PubMed ID: 35344659
[TBL] [Abstract][Full Text] [Related]
7. Theranostic inorganic-organic hybrid nanoparticles with a cocktail of chemotherapeutic and cytostatic drugs.
Khorenko M; Pfeifer J; Napp J; Meschkov A; Alves F; Schepers U; Feldmann C
J Mater Chem B; 2023 Apr; 11(16):3635-3649. PubMed ID: 37017673
[TBL] [Abstract][Full Text] [Related]
8. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
Elzoghby AO; Hemasa AL; Freag MS
J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
